[HTML][HTML] Asiatic acid alleviates cisplatin-induced renal fibrosis in tumor-bearing mice by improving the TFEB-mediated autophagy-lysosome pathway

X Chen, L Huang, J Tang, D Wu, N An, Z Ye… - Biomedicine & …, 2023 - Elsevier
Nephrotoxicity is a major side effect of cisplatin treatment of solid tumors in the clinical
setting. Long-term low-dose cisplatin administration causes renal fibrosis and inflammation …

[HTML][HTML] Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation

C Yang, Y Guo, T Huang, J Zhao, XJ Huang… - Biomedicine & …, 2018 - Elsevier
Cisplatin is a well-known chemotherapeutic drug applied for the treatment of numerous
human cancers. However, the use of cisplatin in clinic is limited by certain serious side …

[HTML][HTML] Retinoic acid alleviates cisplatin-induced acute kidney injury through activation of autophagy

J Wu, C Zheng, X Wan, M Shi, K McMillan… - Frontiers in …, 2020 - frontiersin.org
Cisplatin-induced acute kidney injury (CIAKI) is a common complication in patients receiving
cisplatin-based chemotherapy. But the effective therapies for CIAKI are not available …

[HTML][HTML] Ancient Chinese formula Qiong-Yu-Gao protects against cisplatin-induced nephrotoxicity without reducing anti-tumor activity

ZY Teng, XL Cheng, XT Cai, Y Yang, XY Sun, JD Xu… - Scientific reports, 2015 - nature.com
Cisplatin is a highly effective anti-cancer chemotherapeutic agent; however, its clinical use is
severely limited by serious side effects, of which nephrotoxicity is the most important. In this …

[HTML][HTML] Yishen Xiezhuo formula ameliorates the development of cisplatin-induced acute kidney injury by attenuating renal tubular epithelial cell senescence

Q Zhang, J Qi, Q Luo, M Wu, L Zhang… - Annals of Translational …, 2022 - ncbi.nlm.nih.gov
Background Although cisplatin (DDP) is an important clinical anti-tumor drug, its use is
limited by its nephrotoxicity. How to avoid the renal injury incurred by platinum drugs and …

[HTML][HTML] Celastrol ameliorates cisplatin nephrotoxicity by inhibiting NF-κB and improving mitochondrial function

X Yu, X Meng, M Xu, X Zhang, Y Zhang, G Ding… - …, 2018 - thelancet.com
Background Celastrol is an active ingredient of Chinese medicine Tripterygium wilfordii
which is clinically used to treat the immune diseases. Currently, celastrol is documented as a …

[HTML][HTML] Protective effects of icariin on cisplatin-induced acute renal injury in mice

P Ma, S Zhang, X Su, G Qiu, Z Wu - American Journal of …, 2015 - ncbi.nlm.nih.gov
Cisplatin chemotherapy often causes acute kidney injury in cancer patients. Icariin is a
bioactive flavonoid, which has renal protection and anti-inflammation effects. This study …

LYC inhibits the AKT signaling pathway to activate autophagy and ameliorate TGFB-induced renal fibrosis

Y Wang, Z Ping, H Gao, Z Liu, Q Xv, X Jiang, W Yu - Autophagy, 2024 - Taylor & Francis
Renal fibrosis is a typical pathological change in chronic kidney disease (CKD). Epithelial-
mesenchymal transition (EMT) is the predominant stage. Activation of macroautophagy …

[HTML][HTML] Fenofibrate reduces cisplatin-induced apoptosis by inhibiting the p53/Puma/Caspase-9 pathway and the MAPK/Caspase-8 pathway rather than by promoting …

H Kimura, K Kamiyama, T Imamoto, I Takeda… - … and Biophysics Reports, 2022 - Elsevier
The main lesion of cisplatin nephrotoxicity is damage to proximal tubular cells due to
increased apoptosis via the mitochondrial and death receptor pathways, which may be …

[HTML][HTML] Penicilliumin B protects against cisplatin-induced renal tubular cell apoptosis through activation of AMPK-induced autophagy and mitochondrial biogenesis

W Shen, N Jia, J Miao, S Chen, S Zhou, P Meng… - Kidney diseases, 2021 - karger.com
Introduction: Acute kidney injury (AKI) is at a high prevalence in hospitalized patients,
especially in those receiving chemotherapy. Cisplatin is the most widely used chemotherapy …